Expanding spectrum of illness due to community-associated methicillin-resistant Staphylococcus aureus: a case report by Russell Kempker et al.
Case report
Open Access
Expanding spectrum of illness due to community-associated
methicillin-resistant Staphylococcus aureus: a case report
Russell Kempker1*, Lorenzo Difrancesco2, Alejandro Martin-Gorgojo3
and Carlos Franco-Paredes1
Addresses: 1Department of Infectious Diseases, Emory University School of Medicine, 550 Peachtree Street, MOT 7th Floor Atlanta, GA 30308, USA
2Department of General Medicine, Emory University School of Medicine 69 Jesse Hill Jr, Drive, S.E. Atlanta, GA 30303, USA
3University of Valencia Medical School, Avda Blasco Ibanez 15, Valencia 460101, Spain
Email: RK* - rkempke@emory.edu; LD - ldifran@emory.edu; AMG - margora@alumni.uv.es; CFP - cfranco@emory.edu
*Corresponding author
Received: 23 April 2009 Accepted: 29 July 2009 Published: 17 August 2009
Cases Journal 2009, 2:7437 doi: 10.4076/1757-1626-2-7437
This article is available from: http://casesjournal.com/casesjournal/article/view/7437
© 2009 Kempker et al.; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Xanthogranulomatous pyelonephritis is a rarely identified form of chronic
pyelonephritis usually caused by gram-negative organisms. Herein, we report the first case caused
by infection due to community-associated methicillin-resistant Staphylococcus aureus strain.
Case presentation: An HIV-infected female with a history of intravenous drug use presented with
a three month history of abdominal pain, distension, and fever. Computerized tomography of the
abdomen revealed a large multicystic right kidney mass. During surgical exploration an intrarenal
abscess was identified. Cultures revealed the presence of community-associated methicillin-resistant
Staphylococcus aureus. Histopathological examination demonstrated xanthogranulomatous disease.
The patient was successfully treated with nephrectomy and a prolonged antibiotic combination
regimen with vancomycin and linezolid.
Conclusion: Our case illustrates the escalating spectrum of illness caused by infection due to
community-associated methicillin-resistant Staphylococcus aureus.
Introduction
Infection with methicillin-resistant Staphylococcus aureus
(MRSA) was first reported in the early 1960s, shortly after
the introduction of methicillin and evolved into an
important cause of nosocomial infection. Over the last
three decades the incidence of MRSA infection in the
United States and worldwide has dramatically increased
[1]. The rise in MRSA infections has become an economic
burden on the US health care system and is responsible
for increasing amounts of patient morbidity and mor-
tality. In a recent study by Klevens et al, it was estimated
that 94,360 cases of invasive MRSA infection associated
with death in 18,650 cases occurred in the United States
in 2005 [2]. Reports have also shown MRSA infections to
cause increased rates of morbidity and mortality as
compared to methicillin sensitive Staphylococcus aureus
infections [3,4]. More recently MRSA infection has begun
to emerge in the community setting, with some cases
Page 1 of 4
(page number not for citation purposes)
occurring in patients who have never been hospitalized
and who have no risk factors for MRSA infection. These
cases have been defined as community-associated (CA)
MRSA infections [5].
Strains of MRSA causing epidemiologically defined
community associated and health care associated (HA)
MRSA disease have been shown to be distinct. In a study
comparing CA and HA MRSA infection it was shown that
isolates from the community were more susceptible
to non-B Lactam antibiotics, and more likely to possess
staphylococcal chromosomal cassette mec IV and contain genes
encoding for Panton-Valentine leukocidin (PVL) toxin [6].
Molecular typing studies with pulse field gel electro-
phoresis have defined one pulsed-field type that accounts
for most CA MRSA disease, specified as type USA 300.
In addition CA MRSA infections also tend to be found
more often among healthy, community dwelling persons
without traditional risk factors for MRSA [7].
The rapid evolution of CA MRSA infections has taken
place over the last decade and a half. In 1993, MRSA
infections among western Australian aborigines with no
health care exposure were reported [8]. In 1999, four
cases of rapidly fatal CA MRSA infections in children
from the United States were described [9]. These reports
heralded the rising epidemic of CA MRSA infections. In a
recent population based surveillance study of three
communities in 2001-2002 the CDC found between
8-20% of all MRSA infections were caused by CA MRSA
and an annual disease incidence as high as 25.7/100,000
persons in the general population of Atlanta [10].
In analysis of all community onset skin and soft tissue
infections presenting to a county hospital emergency
room in Atlanta, King et al. found that CA MRSA caused
approximately two-thirds of the cases [11]. While
the majority of CA MRSA infections are skin and
soft tissue infections, CAMRSA may also cause severe
invasive disease [2,6]. Reports of CAMRSA causing life
threatening infections include cases of necrotizing
pneumonia and necrotizing fasciitis [12,13]. Other
emerging clinical syndromes associated with CA MRSA
include Waterhouse-Friderichsen syndrome, empyema,
septic thrombophlebitis, prostatic abscess, and bactere-
mia [14]. In a large case series of CA MRSA infections,
urinary tract infections have been reported to cause up to
4% of CA MRSA infections but none of these cases led to
xanthogranulomatous pyelonephritis (XGP) [10]. This
condition is typically caused by enteric gram-negative
bacilli most commonly Proteus mirabilis or Escherichia coli.
The pathogenesis of XGP is believed to involve a
combination of nephrolithiasis, obstruction, and ascend-
ing infection [15]. We were therefore interested in
reporting a case of XGP associated with CA MRSA in an
HIV-infected patient.
Case presentation
A 52-year-old African American HIV infected female
presented with three months of progressive abdominal
pain, distension, and fever. The patient had never been on
antiretroviral therapy and had a CD4 T-cell count of
396 cells/μL at the time of admission with an unknown
HIV RNA viral load. She had a history of discoid lupus,
hepatitis C, active tobacco, alcohol, and intravenous drug
use (IVDU). The patient had not been hospitalized or seen
in outpatient clinics in the previous year, and was not
taking any medications. She reported living with a family
member and denied any sick contacts.
On examination, the patient was found to be febrile
at 39.6°C. Physical examination was remarkable for
a distended abdomen with right-sided costo-vertebral
tenderness and right lower extremity track marks. On
laboratory analysis, the leukocyte countwas 9240/mclwith
71% segmented neutrophils, the hemoglobin 8.3 gm/dl,
creatinine 1.2mg/dl, and albumin1.9 gm/dl. The rest of the
chemistry panel including amylase and lipase were within
normal. The urinanalysis revealed 5-10 RBC/hpf with no
WBC’s, a negative HCG pregnancy test, and a drug screen
positive for cocaine and opiates.
The patient was admitted to the hospital for further work
up. A computed tomography (CT) scan of the abdomen
and pelvis was done which revealed a 17.5 cm * 12.8 cm
multicystic right-sided renal mass with septations and no
evidence of invasion (Figure 1). The initial diagnostic
Figure 1. Abdominal CT scan revealing a large, complex
cystic mass with multiple enhancing septations and septae
calcifications arising from the right kidney.
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impression was consistent with a multilocular cystic
nephroma. The patient continued to be febrile and was
started empirically on vancomycin and piperacllin-
tazobactam. Urine and blood cultures sent on admission
andmultiple repeat blood cultures throughout the hospital
stay cameback as negative. Twoweeks into her hospital stay
the patient underwent surgical exploration. A large
intrarenal abscess drained over three liters of purulent
material and nephrectomy was subsequently performed.
Cultures grew out MRSA sensitive to erythromycin,
clindamycin, trimethoprim-sulfamethoxazole, levoquin,
gentamycin, vancomycin, and linezolid. Based on this
antibiogram we concluded that this bacterial isolate was
consistent with a CA MRSA strain. Pathologic examination
showed significant necrotic tissue, an abundance of inflam-
matory cells, and foamy histiocytes or xanthoma cells all
characteristic of XGP (Figure 2). After surgery, the patient
received a three-week course of vancomycin switched to
linezolid upon discharge with complete recovery.
Discussion
Xanthogranulomatous pyelonephritis was first described
as a pathological entity in 1916. It is a rare form of chronic
pyelonephritis that results in diffuse renal parenchymal
obstruction. The disease process is traditionally associated
with nephrolithiasis, obstruction, and infection with enteric
gram-negative bacilli, typically Proteus mirabilis or Escherichia
coli. It is unclear if the obstruction or the infection is the
inciting pathological event [15]. Staphylococcus aureus has
rarely been reported as a cause of XGP and to our
knowledge there are no previous reports in the literature
of CA MRSA causing XGP.
Our patient had evidence of XGP caused by MRSA. The
patients MRSA infection met the CDC epidemiological
criteria of CA MRSA, as she had no hospital exposure or
medical procedures such as surgery, dialysis, or catheter
placement during the last year [5]. CA MRSA has also been
shown to be microbiology distinct from health care
associated MRSA infection. In a study by Naimi et al,
comparing the antimicrobial susceptibility pattern of CA
MRSA and HA MRSA infections it was found that
susceptibility to four non-beta Lactam antibiotics was
able to predict a CAMRSA strain with an odds ratio of 2.44
(95% CI, 1.35-3.86) [6]. Our patient’s strain of MRSA met
this microbiological criterion for CA MRSA.
In 1971, Povsil and colleagues were able to experimentally
induce XGP in rats by ligating their ureters and injecting
Escherichia coli into their tails [16]. Few experiments to
further elucidate the mechanisms of pathogenesis have
been done since. In prior case series of XGP, Staphylococcus
aureus has only rarely been identified as a causative agent,
and there has been only one case report of XGP due to
MRSA specifically [15,17]. Our patient’s main risk factor
for infection was her history of intravenous drug use,
which has been associated with outbreaks of CA MRSA
infection [18]. She presented with the common manifesta-
tions of fever and flank pain. We presume her CA MRSA
infection derived from a skin source, given her history of
IVDU and negative blood and urine cultures upon
admission. It is also plausible that she had a prior episode
of undetectable bacteremia and seeded her kidney at that
time. Abreu et al, recently reported 13 cases of retro-
peritoneal infections causes by CAMRSA in which all cases
had preceding skin infections, negative urine cultures, and
only three of the thirteen had positive blood cultures [19].
These findings demonstrate the possibility that retro-
peritoneal CA MRSA infections can come from the skin.
Typical radiological findings of XGP include multiple fluid
filled cavities in the affected kidney with extension of the
disease into the perinephric space. As with our case, XGP is
often confused with other disorders including renal
tuberculosis, pyelonephritis with stones, and renal tumors
and is commonly not included in the differential diagnosis
[20]. XGP is a pathological entity and thus can only be
definitively diagnosed by pathological examination. Our
patient’s pathology exhibited the classic finding of lipid-
laden macrophages mixed with chronic inflammatory
signs. It is hypothesized that bacterial infection provokes
tissue destruction and liberates pericalyceal and necrotic
material, attracting inflammatory cells to the area, includ-
ing macrophages, which take up and become filled with
Figure 2. Histopathology at 40× magnification reveals
characteristic foamy histiocytes as well as scattered plasma
cells and lymphocytes and the absence of any normal renal
tissue.
Page 3 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:7437 http://casesjournal.com/casesjournal/article/view/7437
lipid debris [15]. Our patient made a complete recovery
with the combination of open nephrectomy and a
prolonged antibiotic course. Nephrectomy is considered
the definitive and curative treatment for XGP with
antibiotics serving as adjunctive therapy. There have
been a few case reports of successful outcomes with
antibiotics alone in focal forms of XGP [15]. In addition
there have been reports of good outcomes and shorter
hospital stays with laparoscopic nephrectomies compared
to open nephrectomies [21].
In summary, the clinical spectrum of CA MRSA infections
continues to expand. To our knowledge, this is the first
report of a patient that developed XGP caused by CA
MRSA infection. While the majority of cases produce skin
and soft tissue infections there are increasing reports of
new suppurative manifestations of CA MRSA infections.
Physicians need to be aware of the variety of CA MRSA
infections and keep CA MRSA in the differential when
dealing with a potential case of XGP.
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